TNF Blockers Not Seen To Boost Cancer Risk In RA Patients Tracked In Large Spanish Registry
This article was originally published in The Pink Sheet Daily
Executive Summary
The only elevated cancer type in patients taking the biologic drugs was non-melanoma skin cancer, investigator reports at rheumatology scientific conference.